The Discounted Cash Flow (DCF) valuation of Ligand Pharmaceuticals Inc (LGND) is (163.12) USD. With the latest stock price at 165.51 USD, the upside of Ligand Pharmaceuticals Inc based on DCF is -198.6%.
Based on the latest price of 165.51 USD and our DCF valuation, Ligand Pharmaceuticals Inc (LGND) is a sell. selling LGND stocks now will result in a potential gain of 198.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 8.5% | 7.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (425.74) - (102.36) | (163.12) |
| Upside | -357.2% - -161.8% | -198.6% |